Drugs / Telinavir
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00000806 | — | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Telinavir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000806 ↗ |
| Known as | NSC-670881 | ChEMBL registry synonym — accepted as the source's own label CHEMBL322241 ↗ |
| Known as | SC-52151 | ChEMBL registry synonym — accepted as the source's own label CHEMBL322241 ↗ |
| Modality | Small molecule | — CHEMBL322241 ↗ |